MLTX: MoonLake Immunotherapeutics - Class A

55.65 USD 2.73 (5.16%)

Sector: Atención Sanitaria Básica: US Dollar Divisa de beneficio: US Dollar

El tipo de cambio de MLTX de hoy ha cambiado un 5.16%. En este caso, el precio mínimo en el mercado ha alcanzado 54.44, mientras que el máximo ha alcanzado 55.96.

Siga la dinámica de la pareja de divisas MoonLake Immunotherapeutics - Class A. El gráfico histórico le mostrará cómo ha cambiado el precio de %AssetName% en el pasado. Alternando entre diferentes marcos temporales, podrá monitorear las tendencias y la dinámica del tipo de cambio por minutos, horas, días, semanas y meses. Use esta información para predecir los cambios en el mercado y tomar decisiones comerciales fundamentadas.

Gráfico a pantalla completa

MLTX News

Seeking Alpha 19:52 MoonLake Immunotherapeutics: Maintaining A Small Holding (NASDAQ:MLTX)
Investing 17:12 Guggenheim reiterates Buy rating on Moonlake Immunotherapeutics stock
Benzinga 18:08 Merck's Keytruda Secures FDA Nod For Head And Neck Cancer As First Immunotherapy For Use Around Surgery - Merck & Co (NYSE:MRK)
Seeking Alpha 19:08 MoonLake Immunotherapeutics: More Sonelokimab Success, With Big Pharma Interest (MLTX)
Benzinga 15:02 Signet Posts Upbeat Earnings, Joins Ferguson Enterprises, Dollar General And Other Big Stocks Moving Higher On Tuesday - Credo Technology Group (NASDAQ:CRDO), Algonquin Power (NYSE:AQN)
Investing 14:18 RBC Capital maintains outperform rating on Moonlake stock
Investor's Business Daily 13:27 MoonLake Immunotherapeutics Catapults On Rumored $3 Billion Merck Takeover Bid
Benzinga 11:38 Merck's Dealmaking Intensifies With MoonLake Bid As Keytruda Patent Cliff Nears: Report - MoonLake (NASDAQ:MLTX), Merck & Co (NYSE:MRK)
Investing 10:40 Guggenheim reaffirms Buy rating on Moonlake stock amid M&A talks
Benzinga 10:30 Why Credo Technology Group Shares Are Trading Higher By Over 14%; Here Are 20 Stocks Moving Premarket - Agenus (NASDAQ:AGEN), Bumble (NASDAQ:BMBL)
Reuters 21:31 Merck held talks to buy biotech MoonLake for over $3 billion, FT reports
Investing 21:29 MoonLake Immunotherapeutics stock surges on FT report of Merck buyout talks
Investing 21:08 Merck held talks to buy biotech MoonLake for over $3 billion, FT reports
Investing 11:30 H.C. Wainwright maintains $100 target on Moonlake stock
Investing 15:17 Wolfe Research lifts Moonlake stock to Outperform
Seeking Alpha 07:31 MoonLake Immunotherapeutics: A Buy At Dips (NASDAQ:MLTX)
Benzinga 15:36 This West Pharmaceutical Services Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday - Bloom Energy (NYSE:BE), Alpha Cognition (NASDAQ:ACOG)

Rango diario

54.44 55.96

Rango anual

31.42 58.26

Cierres anteriores: 52.92
Open: 54.95

Bid: 55.65
Ask: 55.95

Low: 54.44
High: 55.96

Volumen: 901

Cambio diario: 5.16%
Cambio mensual: 11.17%

Cambio a 6 meses: 32.06%
Cambio anual: 19.16%

14 agosto, jueves